Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Inozyme Pharma Inc
(NQ:
INZY
)
5.400
+0.290 (+5.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inozyme Pharma Inc
< Previous
1
2
3
4
5
Next >
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 31, 2023
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
Via
Benzinga
Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
March 31, 2023
The Dow Jones closed higher by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or ...
Via
Benzinga
Why Safe & Green Holdings Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
March 30, 2023
Gainers Boxed, Inc. (NYSE: BOXD) gained 43.3% to $0.2303 in pre-market trading after declining 6% on Wednesday. Boxed recently said it is evaluating potentially filing for relief under the U.S....
Via
Benzinga
4 Analysts Have This to Say About Inozyme Pharma
March 23, 2023
Via
Benzinga
Why Inozyme Pharma (INZY) Shares Are Trading Higher Today
February 16, 2023
Via
Benzinga
$1.6M Bet On ATAI Life Sciences? Check Out These 4 Penny Stocks Insiders Are Buying
March 30, 2023
The Dow Jones closed higher by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
March 23, 2023
Via
Benzinga
89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday
March 23, 2023
Baird cut the price target for Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) from $14 to $11. Baird analyst Justin Kleber maintained an Outperform rating. Petco Health and Wellness shares rose...
Via
Benzinga
Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
March 22, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 20, 2023
Via
Benzinga
Dow Drops 100 Points; Deere Earnings Top Estimates
February 17, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Friday. Following the market opening Friday, the Dow traded down 0.30% to 33,594.11 while the NASDAQ fell 0.86%...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 16, 2023
Via
Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.
Via
Benzinga
Nasdaq Drops 150 Points; US Producer Prices Rise 0.7% In January
February 16, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 150 points on Thursday. Following the market opening Thursday, the Dow traded down 1.14% to 33,738.17 while the NASDAQ...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 16, 2023
Via
Benzinga
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 16, 2023
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.
Via
Benzinga
Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
February 16, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma to Host Virtual Investor and Analyst Event on Feb. 16, 2023
February 06, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Why Applied UV Shares Are Trading Higher By 46%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 27, 2023
Gainers FOXO Technologies Inc. (NYSE: FOXO) shares jumped 109% to $1.07. Akanda Corp. (NASDAQ: AKAN) rose 59% to $0.4459 after jumping 47% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 27, 2023
Via
Benzinga
US Stocks Higher; Dow Rises 150 Points
January 27, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 50 points on Friday. Following the market opening Friday, the Dow traded up 0.47% to 34,107.87 while the NASDAQ rose 0.55% to...
Via
Benzinga
Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress
January 09, 2023
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence of ENPP1 Deficiency
December 05, 2022
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma to Participate at the BofA Securities Biotech SMID Cap Conference
December 01, 2022
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 10, 2022
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma to Participate in Upcoming Investor Conferences
November 07, 2022
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma Announces First Self-Administration of INZ-701 in Ongoing ENPP1 Deficiency Phase 1/2 Clinical Trial
November 03, 2022
From
Inozyme Pharma Inc.
Via
GlobeNewswire
Inozyme Pharma Announces Publication of Comprehensive ENPP1 Variant Database
October 31, 2022
From
Inozyme Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 28, 2022
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.